Arovella speaking at ANZ Biologics Festival

Presentations & WebinarsAll
Written by Michelle Long

Arovella’s Chief Operating Officer, Dr Nicole van der Weerden, is speaking today at the ANZ Biologics Festival. Dr van der Weerden is speaking about the development of CAR-iNKT cells for the treatment and haematological malignancies and solid tumours.

View presentation

 
Michelle Long
Previous

Letter from Managing Director & CEO
Next

Arovella’s IND for ALA-101 accepted by the U.S. Food and Drug Administration